CRL vs OTIS · rev $2.00B vs P/E 19, rev $7.42B
Charles River Laboratories (CRL) versus Otis Worldwide Corp (OTIS) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Otis Worldwide Corp (OTIS) is a specialty industrial machinery company listed on NYSE.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported OTIS revenue for 2026-06-30 was $7.42B. Net income was $768.0M. OTIS currently screens at market cap $27.90B and trailing P/E 19.3.
CRL currently screens at market cap $7.78B. OTIS currently screens at market cap $27.90B and trailing P/E 19.3.
Not investment advice. Open the CRL and OTIS stock pages for the full models.
Not investment advice.